RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Learning strategies for everyday goals

This study tests a structured approach designed to help people with Parkinson's learn tasks while avoiding errors.

Testing a treatment or activity · Study reference: NL-OMON55102

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date)
2021-12-22

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 18 to 99 · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: Not reported

Inclusion criteria: • Parkinson*s disease diagnosed according to the UK Brain Bank criteria. • Age between 35-80 years • Experience of cognitive complaint / Cognitive deficits (neuropsychological assessment or questionnaire) • Living independently at home • Hoehn & Yahr (H&Y) symptoms of Parkinson's disease <= 3 (i.e. patients have to be mobile in order to visit the participating center) Exclusion criteria: • Inability to speak/understand the Dutch language • Severe language or perceptual impairment • Low premorbid level of intellectual functioning (IQ < 80) • Severe psychiatric problems (history) • Substance abuse • Severe cognitive comorbidity (i.e. dementia; MMSE or Moca <= 24)
Full study name & original research details

Official study title

Errorless learning and Goal Management Training in Parkinson*s disease - EL - GMT in Parkinson

Short title used by the registry

Errorless learning and Goal Management Training in Parkinson*s disease

Original description

Intervention: The investigational treatment is based on the standard GMT. The investigational treatment will have an errorless learning approach meaning that both learning and applying the algorithm of GMT will be learned errorless. This means that the multiple steps of the GMT as well as the actual performance of the IADL-tasks will be learned without the occurrence of errors under guidance of a therapist. In standard GMT (comparator) errors do occur. Patients will learn to use algorithm and the performance of the tasks using trial and error. The therapist is in this group not responsible for preventing errors during learning and applying GMT. Both types of GMT will consist of 8 sessions (max. 60 minutes) and will be given twice a week. Primary outcome: The main study parameter is a standardized scale measuring performance of IADL tasks before (baseline) and after treatment (post treatment). IADL tasks will be divided into multiple steps using the GMT method. These step will be assessed using three categories: 1) competent; 2) questionable/ineffective 3) deficit, using task-specific assessment forms. Secondary outcome: A secondary study parameter is the subjective experience of cognitive deficits of participants, measured by the Goal Attainment Scale (GAS) and is performed before the intervention (baseline), immediately after the intervention (post-treatment) and 4 months later (follow-up) . Goal attainment scaling is a mathematical technique for quantifying the achievement of goals set, used in rehabilitation. GAS is described as a method of scoring the extent to which patient*s individual goals are achieved in the course of the intervention. In effect, each patient has own outcome measures, but this is scored in a standardized way as to allow statistical analysis.

Conditions reported: degenerative brain disease Parkinson's Disease;10029305

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
The investigational treatment is based on the standard GMT. The investigational treatment will have an errorless learning approach meaning that both learning and applying the algorithm of GMT will be learned errorless. This means that the multiple steps of the GMT as well as the actual performance of the IADL-tasks will be learned without the occurrence of errors under guidance of a therapist. In standard GMT (comparator) errors do occur. Patients will learn to use algorithm and the performance of the tasks using trial and error. The therapist is in this group not responsible for preventing errors during learning and applying GMT. Both types of GMT will consist of 8 sessions (max. 60 minutes) and will be given twice a week.
Phases
Not reported
Sponsor
Radboud Universiteit Nijmegen
Start date reported by registry
2021-12-22 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Netherlands

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.